—

Smith & Nephew SNATS Inc(SNN)— 同类公司组

数据截至2026-10-26 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Smith & Nephew SNATS Inc的Closelook综合评分为58/100,在同类公司组内排名第4位(共7家)——组内评分最高的是DexCom Inc(65/100)。

名称综合动量质量估值信号距52周高点
SNN Smith & Nephew SNATS Inc58455672info16.6%
DXCM DexCom Inc65778036bear15.8%
GMED Globus Medical61446558neutral19.7%
SECT-B.ST Sectra AB (publ)61896711bull0.9%
CEVI.ST CellaVision AB56837030bull9.7%
SOON.SW Sonova H Ag56947350bull0.4%
SYK Stryker Corporation53366743watch21.3%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-26

Quick answers

Smith & Nephew SNATS Inc在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:DexCom Inc (DXCM)、Globus Medical (GMED)、Sectra AB (publ) (SECT-B.ST)、CellaVision AB (CEVI.ST)、Sonova H Ag (SOON.SW)、Stryker Corporation (SYK)。

SNN相对同类公司的评分如何?

Smith & Nephew SNATS Inc的综合评分为58/100,组内排名第4位(共7家),截至2026-10-26;组内最高综合评分为DexCom Inc(65/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.